Stock·NYSE·Industrials
United Rentals Inc. (URI)
- Market cap
- $64.09B
- P/E
- 25.19
- Dividend yield
- 0.75%
- Street target
- $1,317.00median of 22 analysts
- 52-week range
- $701.59 $1,179.18
The short version
Where URI stands today, in four lines, and what CleaRank Financial AI makes of it.
URI at a glance
United Rentals Inc. (URI): Buy, 73/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($959.70 and $1,052.35).
- Earnings URI beat estimates in 3 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $34.7M and bought $53K over the last 18 months.
- Valuation P/E of 25.2 against 34.0 for the Industrials sector: a discount to peers (-26%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates United Rentals Inc. (URI) Buy, with a model score of 73/100.
The trend lifts the score most: the price is 7.29% above its 200-day average, and the 50-day average is 9.65% above the 200-day. The 50-day average stands at $1,052.35 and the 200-day at $959.70. Over the past year the price rose 2.39%.
Only on CleaRank
Figures we compute ourselves from URI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $1,029.64 is 2.2% below the 50-day simple moving average of $1,052.35.Price above its 200-day average ›
The price is 7.3% above the 200-day simple moving average of $959.70.50-day average above the 200-day ›
The 50-day average ($1,052.35) is 9.7% above the 200-day average ($959.70), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 69% of its 52-week range, between $701.59 and $1,179.18.
URI share price
Pick a period: each tab shows how far URI has moved over it, to the last close.
Today's trading
Where URI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 25.19 is 25.9% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 3.87 is 3.2% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $2.6B on revenue of $16.8B, a net margin of 15.7%.Beat estimates in most recent reports ›
URI beat the EPS estimate in 3 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.75%, or $7.70 a share a year.
Key statistics
The headline figures for URI.
As of October 17, 2026, URI trades at $1,029.64, with a market value of $64.09B, a P/E ratio of 25.19 and a dividend yield of 0.75%.
What the numbers say
CleaRank Financial AI's reading of URI's valuation, growth and risks.
Measured by earnings, URI trades at 25.19 times, compared with a median of 34.0 for Industrials. That gap makes it a discount to peers, with the P/E 25.9% below the sector median. Its price-to-sales ratio of 3.87 is 3.3% below the sector median of 4.0. Trailing earnings stand at $41.59 per share.
URI is growing faster than its peers: revenue rose 11.80% in the latest year, compared with a sector median of 11.7%. Its net margin of 15.67% and operating margin of 25.99% show healthy profitability, and its return on equity of 28.90% sits above the sector median of 17.8%. On the balance sheet, debt-to-equity stands at 1.67. The trailing dividend yield is 0.75%, which works out to $7.70 per share each year.
URI's most recent earnings report, released on July 22, 2026, topped the estimate by 10.09%. The company reported EPS of $12.76, while analysts had expected $11.59. In the first session after the report, the share price climbed 10.11%.
The earnings record shows 3 beats in 7 reports, and every one of those beats was followed by a gain the next day. The April 22, 2026 report stands out among the earlier ones: a beat of 8.61%, after which the stock rose 22.92%. Looking ahead, analysts expect EPS of $49.30 this fiscal year (growth of 17.2%) and $57.35 the year after (growth of 16.3%).
On an average day, URI's shares move 1.90%.
URI against the Industrials sector
How URI compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: URI trades at a notable discount to sector peers (-26%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 6, 2025, URI has gained 58.0% against a gain of 25.7% for XLI.
Performance against XLI
URI and the Industrials sector fund over the same days.
Revenue and earnings
How much URI sells, and how much of it becomes profit.
Revenue growth: Revenue grew 4.9% in FY2025 to $16.1B, from $15.3B a year earlier.
Profit margin: The net margin was 15.5% in FY2025, down from 16.8% the year before.
Profitable: URI earned $2.5B in FY2025.
Earnings reality check
Did URI beat what analysts expected, and how did the stock react?
Earnings record: URI beat the analyst estimate in 3 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2026after close | $11.59 | $12.76 | +10.09% | +10.11% | +1.94% |
| Apr 22, 2026after close | $8.94 | $9.71 | +8.61% | +22.92% | +18.60% |
| Jan 28, 2026after close | $11.80 | $11.09 | -6.02% | -12.86% | -6.10% |
| Jul 23, 2025after close | $10.54 | $10.47 | -0.66% | +8.96% | +9.61% |
| Apr 23, 2025after close | $8.81 | $8.86 | +0.57% | +9.87% | +7.17% |
| Jan 29, 2025after close | $11.63 | $11.59 | -0.34% | +2.07% | -2.66% |
| Oct 23, 2024after close | $12.49 | $11.80 | -5.52% | -1.10% | -2.64% |
As of October 17, 2026, URI has beaten the analyst EPS estimate in 3 of its last 7 reported quarters and rose in the first trading session after every one of those beats; its latest report, on July 22, 2026, came in 10.09% above the estimate and the stock moved +10.11% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 46.7, in neutral territory.RSI above 50 ›
An RSI of 46.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of URI
The score, the reasoning behind it, and what could move the price next.
URI's trend signal is mixed. At $1,029.64, the stock sits 2.16% below its 50-day average of $1,052.35, yet it is 7.29% above its 200-day average of $959.70. The 50-day average is 9.65% above the 200-day, so the longer-term averages have not yet caught up with the softer recent price. Over the past year, the price is 46.76% above the 52-week low of $701.59 and 12.68% below the 52-week high of $1,179.18.
The short and long run point different ways: the price rose 2.32% over the past month, fell 1.49% over the past three months and rose 2.39% over the past year. The 14-day RSI of 46.7 is in the neutral zone, and the MACD line is positive.
Earnings beat ›
The July 22, 2026 report beat the EPS estimate by 10.09%, and the share price rose 10.11% in the first session after it.
Source: Earnings report, July 22, 2026Rating reaffirmed ›
Truist Securities kept its Buy rating on October 5, 2026.
Source: Analyst action, Truist Securities, October 5, 2026
Analyst downgrade ›
JP Morgan downgraded it to Neutral from Overweight on September 10, 2026.
Source: Analyst action, JP Morgan, September 10, 2026
- The two levels to track are the 20-day EMA at $1,043.21, just above the price, and the 200-day SMA at $959.70, just below it.
- A 14-day RSI of 46.7 sits in the neutral zone, and the MACD line is positive. Readings above 70 or below 30 signal stretched momentum.
- Following the July 22, 2026 report, the share price climbed 10.11% in the first session. Across the last 7 reports, URI has beaten estimates 3 times.
URI sits in a mixed trend: the price is above the 200-day average of $959.70 but below the 50-day average of $1,052.35. Reclaiming the 50-day with a close above it would turn both signals higher, while a close below the 200-day would turn both lower. Looking at the nearest levels, the 200-day SMA at $959.70 lies beneath the price and the 20-day EMA at $1,043.21 lies above it.
A 14-day RSI of 46.7 places URI in the neutral zone, which runs from 40 to 60.
Technical indicators
Momentum and trend for URI, from its daily closes.
As of October 17, 2026, with URI at $1,029.64, its 14-day RSI is 46.7 (neutral territory), its 50-day simple moving average is $1,052.35 and its 200-day is $959.70.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What URI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, URI's 1-year correlation of daily returns is +0.52 with S&P 500 (SPY), +0.46 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
16 of 22 analysts rate it a buy or strong buy, 5 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $1,317.00 is 27.9% above the price.More buy ratings than three months ago ›
16 of 22 rate it a buy now, against 17 of 22 three months ago.
URI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | Truist Securities | Maintains | Buy |
| Sep 24, 2026 | RBC Capital | Reiterates | Outperform |
| Sep 10, 2026 | JP Morgan | Downgrade | Neutral |
| Aug 11, 2026 | Evercore ISI Group | Maintains | Outperform |
| Aug 4, 2026 | Argus Research | Reiterates | Buy |
| Jul 25, 2026 | UBS | Maintains | Buy |
As of October 17, 2026, 22 Wall Street analysts cover URI: 16 rate it a buy or strong buy, 5 a hold and 1 a sell or strong sell. Their 12-month price targets range from $950.00 to $1,610.00, with a median of $1,317.00, 27.9% above the price of $1,029.64.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
URI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from URI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much URI tends to move, against the market and on its own.
The long record
URI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.90% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 59.0%, from March 2018 to March 2020, regained by October 2020.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $141,275, against $42,055 in the S&P 500 (SPY).
URI Drawdowns & Recovery
As of October 17, 2026, URI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -59.0% (March 2018 to March 2020); it regained that peak by October 2020, 7 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into URI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: URI beat the S&P 500 over this period: $141,275 against $42,055.
A $10,000 investment in URI in October 2016 would be worth about $141,275 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to URI, and which have not.
Strongest month, November: an average of +10.98%, up in 9 of 10 years.
Weakest month, March: an average of -6.21%, up in 4 of 10 years.
This month, October: has averaged -2.27%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, URI's strongest calendar month has been November (average +10.98%, up in 9 of 10 years) and its weakest March (average -6.21%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in URI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in URI today could grow to about $29,204 by 2036 in the base case, with a 90th-percentile outcome near $160,755 and a 10th-percentile outcome around $5,306. The simulation models price only; at today's 0.75% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
URI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,581 for URI by 2030 in the base case, from $1,030 today (1.5x over 4 years). The 10th-percentile path ends near $538. These are outcomes of a Monte Carlo simulation run on URI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $668 | $1,146 | $1,965 | |
| 2028 | $595 | $1,276 | $2,735 | |
| 2029 | $558 | $1,420 | $3,614 | |
| 2030 | $538 | $1,581 | $4,649 | |
| 2031 | $527 | $1,760 | $5,877 |
Method: a lognormal simulation of URI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
URI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $53K on the open market and sold $34.7M.
As of October 17, 2026, URI insiders reported 11 open-market sales worth $34.7M and 1 open-market purchase worth $53K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | William E. Grace
Chief Financial Officer
|
Sell | 1.5K | $1.7M |
| Jun 30, 2026 | Marc A Bruno
Director
|
Grant | 34 | $38.5K |
| May 8, 2026 | Marc A Bruno
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Shon Larry D De
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Brandt Julie M Heuer
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Kim Harris Jones
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Terri L Kelly
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Francisco J Lopez-Balboa
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Gracia C Martore
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Shiv Singh
Director
|
Grant | 203 | $190.2K |
| May 8, 2026 | Alexander R Taussig
Director
|
Grant | 203 | $190.2K |
| Apr 27, 2026 | Craig Adam Pintoff
Officer
|
Sell | 2.5K | $2.4M |
| Apr 27, 2026 | Joli Lyn Gross
Officer
|
Sell | 306 | $292.2K |
| Apr 24, 2026 | Matthew John Flannery
Chief Executive Officer
|
Sell | 22.8K | $22.4M |
| Apr 24, 2026 | Andrew B Limoges
Officer
|
Sell | 548 | $535.9K |
| Mar 31, 2026 | Marc A Bruno
Director
|
Grant | 51 | $37.2K |
| Mar 4, 2026 | Michael Duane Durand
Chief Operating Officer
|
Grant | 1.3K | $1.1M |
| Mar 4, 2026 | Matthew John Flannery
Chief Executive Officer
|
Grant | 3.6K | $3.1M |
| Mar 4, 2026 | William E. Grace
Chief Financial Officer
|
Grant | 1.3K | $1.1M |
| Mar 4, 2026 | Joli Lyn Gross
Officer
|
Grant | 791 | $673.8K |
| Mar 4, 2026 | Anthony S Leopold
Officer
|
Grant | 651 | $554.6K |
| Mar 4, 2026 | Andrew B Limoges
Officer
|
Grant | 398 | $339.0K |
| Mar 4, 2026 | Craig Adam Pintoff
Officer
|
Grant | 1.7K | $1.4M |
| Feb 17, 2026 | Alexander R Taussig
Director
|
Grant | 57 | $48.3K |
| Feb 3, 2026 | William E. Grace
Chief Financial Officer
|
Sell | 1.5K | $1.2M |
| Feb 2, 2026 | Michael Duane Durand
Chief Operating Officer
|
Sell | 2.5K | $2.0M |
| Feb 2, 2026 | Shiv Singh
Director
|
Grant | 68 | $53.3K |
| Feb 2, 2026 | Shiv Singh
Director
|
Buy | 68 | $53.3K |
| Jan 28, 2026 | Michael Duane Durand
Chief Operating Officer
|
Grant | 2.2K | $2.0M |
| Jan 28, 2026 | Matthew John Flannery
Chief Executive Officer
|
Grant | 12.2K | $11.0M |
| Jan 28, 2026 | William E. Grace
Chief Financial Officer
|
Grant | 2.5K | $2.3M |
| Jan 28, 2026 | Joli Lyn Gross
Officer
|
Grant | 1.4K | $1.3M |
| Jan 28, 2026 | Anthony S Leopold
Officer
|
Grant | 1.1K | $1.0M |
| Jan 28, 2026 | Andrew B Limoges
Officer
|
Grant | 612 | $552.8K |
| Jan 28, 2026 | Craig Adam Pintoff
Officer
|
Grant | 3.7K | $3.3M |
| Dec 31, 2025 | Marc A Bruno
Director
|
Grant | 47 | $38.0K |
| Sep 30, 2025 | Marc A Bruno
Director
|
Grant | 40 | $38.2K |
| Sep 3, 2025 | Andrew B Limoges
Officer
|
Grant | 25 | - |
| Jun 30, 2025 | Marc A Bruno
Director
|
Grant | 46 | $34.7K |
| May 13, 2025 | Joli Lyn Gross
Officer
|
Sell | 345 | $250.1K |
| May 12, 2025 | Andrew B Limoges
Officer
|
Sell | 708 | $499.8K |
| May 8, 2025 | Marc A Bruno
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Shon Larry D De
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Brandt Julie M Heuer
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Kim Harris Jones
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Terri L Kelly
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Francisco J Lopez-Balboa
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Gracia C Martore
Director
|
Grant | 284 | $190.3K |
| May 8, 2025 | Shiv Singh
Director
|
Grant | 284 | $190.3K |
| Apr 29, 2025 | Michael Duane Durand
Chief Operating Officer
|
Sell | 1.1K | $688.9K |
| Apr 28, 2025 | Craig Adam Pintoff
Officer
|
Sell | 4.4K | $2.8M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.